Tag: Acute lymphoblastic leukemia

Alembic Pharmaceuticals gets FDA approval for Dasatinib Tablets

pallavi123- June 12, 2022

Alembic Pharmaceuticals has secured tentative approval for the abbreviated new drug application (ANDA) of Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 ... Read More

Jazz Pharmaceuticals gets Rylaze FDA approval for ALL and LBL

pallavi123- July 3, 2021

Rylaze FDA approval : Jazz Pharmaceuticals has secured approval for its leukemia drug Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn or JZP458) from the US Food and ... Read More

Amgen blood cancer drug BLINCYTO scores EC approval in pediatric patients

pharmanewsdaily- August 30, 2018

The European Commission (EC) has approved an expanded indication for Amgen blood cancer drug BLINCYTO (blinatumomab) as monotherapy for the treatment of certain form of ... Read More

Pfizer’s blood cancer drug inotuzumab ozogamicin gets FDA priority review

pharmanewsdaily- February 23, 2017

Pfizer’s blood cancer drug, inotuzumab ozogamicin has secured a priority review designation from the US Food and Drug Administration (FDA). Inotuzumab ozogamicin has been developed ... Read More